Fresenius Medical Care AG (FMCQF) Gains from Sales and Divestitures (2017)

Fresenius Medical Care AG (FMCQF) posted quarterly Gains from Sales and Divestitures of $32.2 million for Q4 2017, up 510.23% year-over-year from $5.3 million in Q4 2016, and up 510.23% on a QoQ basis from $5.3 million in Q4 2016.

Fresenius Medical Care AG (FMCQF) Gains from Sales and Divestitures (2017) Analysis & Trends

Fresenius Medical Care AG (FMCQF) has reported Gains from Sales and Divestitures for 2 consecutive years, with $32.2 million the latest figure, recorded in Q4 2017.

  • In Q4 2017, Gains from Sales and Divestitures rose 510.23% year-over-year to $32.2 million; the TTM figure through Dec 2017 stood at $32.2 million (up 510.23% YoY), while the FY2017 annual figure was $32.2 million, up 510.23% from the prior year.
  • Gains from Sales and Divestitures came in at $32.2 million for Q4 2017 at Fresenius Medical Care AG, up from $5.3 million in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $32.2 million in Q4 2017, with the low at $5.3 million in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn
10 Fresenius Medical Care AG - - 19.45 Bn

Historic Data

Download Data
DateValue
Dec 31, 2017 32.17 Mn
Dec 31, 2017 32.17 Mn